Literature DB >> 2436103

Aggression and defeat-induced opioid analgesia displayed by mice are modified by calcium channel antagonists and agonists.

M Kavaliers.   

Abstract

The effects of the calcium channel antagonists diltiazem, nifedipine and verapamil and the calcium channel agonist, BAY K 8644, on offensive and defensive aggression and defeat-induced opioid analgesia were examined in male mice in resident-intruder interactions. The calcium channel antagonists decreased and the agonist increased the aggressive behaviors displayed by the mice. In addition, the calcium channel antagonists augmented, while the agonist attenuated defeat-induced analgesia displayed by the intruder mice. These results suggest that calcium channel antagonists have inhibitory influences on aggressive behavior and may facilitate endogenous opioid activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436103     DOI: 10.1016/0304-3940(87)90060-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Effect of repetitive electroconvulsive treatment on sensitivity to pain and on [3H]nitrendipine binding sites in cortical and hippocampal membranes.

Authors:  L Antkiewicz-Michaluk; J Michaluk; I Romańska; J Vetulani
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Calcium channel involvement in magnetic field inhibition of morphine-induced analgesia.

Authors:  M Kavaliers; K P Ossenkopp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

3.  Alteration in hypnotic effect of pentobarbital following repeated agonistic confrontations in mice.

Authors:  S Ohdo; H Yoshimura; N Ogawa
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.

Authors:  M Barrios; I Robles; J M Baeyens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.